15 Jul 2021

Lactobacillus rhamnosus GG, API

PDF 689 kB

L. rhamnosus GG (ATCC53103) is the most studied probiotic strains worldwide with over 1000 publications, and especially recommended in pediatric diarrhea management and antibiotic-associated diarrhea but also studied across a number of other functionalities. We propose this strain in high quality, allergen-free, high concentration and as Active Pharmaceutical Ingredient, backed by the Drug Master File, for your pharmaceutical development.

Content provided by our supplier

Probiotical S.p.A.

  • IT
  • 2017
    On CPHI since
  • 50 - 99
Company types

Other Content from Probiotical S.p.A. (2)

  • News Probiotical white paper_immune defenses high definition

    An effective immune system is your best defense, and the right probiotics can help! The COVID-19 global crisis has led to a peak in demand for products able to stimulate immunity. Given the well-established importance of the microbiota in immune health, Chinese authorities have emitted in February an official recommendation for the use of probiotics in the treatment of patients with severe COVID-19 infection (1, 2).
  • Video Bifizen Range

    Bifizen is a probiotic combination of 4 strains selected for complementary mechanisms of action to benefit the gut-brain axis: L. fermentum LF16, L. rhamnosus LR06, B. longum 04 and L. plantarum LP01. Bifizen supplementation for 6 weeks in healthy students showed significant benefits in depressive mood, anger, fatigue and quality of sleep. The product is now declined as a range for mental well-being for the whole family.